Twitxy Saved

Aditi Shastri, MD

@aditishasMD

Assoc Prof, Physician-scientist researching cures for AML & MDS. Addressing health disparities in cancer care. #shastrilab Tweets my own #leusm #mds
New York, NY einstein.yu.edu/faculty/14819/… Joined June 2017
438 Following 2K Followers 3.6K Posts

Latest posts 5

Aditi Shastri, MD @aditishasMD
Excited to have metronomic Dac/ Ven in TP53 MDS / AML from our group @MontefioreNYC lead by @MendelGoldfing2 in @Haematologica . ORR of 70% in AML with 11.6 median OS in TP53 mutant AML , 10.4 mos median OS in bialleilic TP53! A step in the right direction! 🎉#leusm #leukemia
Mendel Goldfinger @MendelGoldfing2 Apr 7
Improved outcomes in TP53-mutated MDS/AML without added toxicity.
Metronomic decitabine /venetoclax.
Haematologica
doi.org/10.3324/haemat…
@Amitvermamds @aditishasMD @YannisMantz @Saunthararajah @SteidlUli @mkonople @EinsteinMed @MontefioreNYC
View quoted post on X
1 replies 4 reposts 48 likes 3.4K views View on X
Aditi Shastri, MD @aditishasMD
In our study just published in @BloodCancerJnl Outdoor Air Pollution(OAP) , particularly PM2.5 was associated with a trend towards worse survival in #multiplemyeloma patients treated in a historically redlined area - Bronx, NY. @Einstein_SCI @MontefioreNYC @EinsteinMed
Fine particulate matter exposure is linked to worse myeloma outcomes in a diverse urban cohort | Blood Cancer Journal ⁦@aditishasMD⁩ nature.com/articles/s4140…
View quoted post on X
1 replies 11 reposts 40 likes 9.6K views View on X
Aditi Shastri, MD @aditishasMD
Practice-changing study from @YannisMantz @MontefioreNYC in @BloodJournal adding Ven frontline to globally used AML doublet 3+7 ⬆️ response rates ⬆️application. Happy to be a part of it! #leusm @Einstein_SCI
🔥 Excited for our Phase 1 study Ven + 7+3 for Newly Diagnosed AML
demonstrating 85% CR (86% MRD-neg)
@BloodJournal @ MontefioreNYC @EinsteinMed @MontefioreNYC
Eric J. Feldman @MendelGoldfing2
@mkonople @Amitvermamds @aditishasMD @Gritsman_lab
#leusm

doi.org/10.1182/blood.…
View quoted post on X